ACOG: Progression to Severe Chronic Hypertension 5–7 Years After a Pregnancy With Mild Chronic Hypertension

Progression to Severe Chronic Hypertension 5–7 Years After a Pregnancy With Mild Chronic Hypertension OBJECTIVE: To estimate the incidence of severe chronic hypertension (cHTN) within 5–7 years after a pregnancy…

Read More from ACOG: Progression to Severe Chronic Hypertension 5–7 Years After a Pregnancy With Mild Chronic Hypertension

ACOG: Racial and Ethnic Disparities in Primary Cesarean Birth and Adverse Outcomes Among Low-Risk Nulliparous People

Racial and Ethnic Disparities in Primary Cesarean Birth and Adverse Outcomes Among Low-Risk Nulliparous People OBJECTIVE: To compare trend of primary cesarean delivery rate and composite neonatal and maternal adverse…

Read More from ACOG: Racial and Ethnic Disparities in Primary Cesarean Birth and Adverse Outcomes Among Low-Risk Nulliparous People

ACOG: Using Longitudinally Linked Data to Measure Severe Maternal Morbidity Beyond the Birth Hospitalization in California

Using Longitudinally Linked Data to Measure Severe Maternal Morbidity Beyond the Birth Hospitalization in California Most studies of severe maternal morbidity (SMM) include only cases that occur during birth hospitalizations….

Read More from ACOG: Using Longitudinally Linked Data to Measure Severe Maternal Morbidity Beyond the Birth Hospitalization in California

ACOG Practice Advisory: Low-Dose Aspirin Use for the Prevention of Preeclampsia and Related Morbidity and Mortality

Background Low-dose aspirin has been used during pregnancy most commonly to prevent or delay the onset of preeclampsia 1. The previous recommendation from the American College of Obstetricians and Gynecologists…

Read More from ACOG Practice Advisory: Low-Dose Aspirin Use for the Prevention of Preeclampsia and Related Morbidity and Mortality

ACOG: What Obstetrician–Gynecologists Should Know About Substance Use Disorders in the Perinatal Period

ABSTRACT Substance use in pregnancy is common; nearly one of five of pregnant individuals have past-month nicotine, alcohol, or illicit substance use, and more than one in 10 meet criteria…

Read More from ACOG: What Obstetrician–Gynecologists Should Know About Substance Use Disorders in the Perinatal Period

ACOG: Identifying Cases of Severe Maternal Morbidity – Moving Beyond the Delivery Hospitalization

Accounting for adverse events and outcomes related to maternity is fundamental to measuring the health of populations and the systems for delivering medical care. Traditionally, maternal mortality has been such…

Read More from ACOG: Identifying Cases of Severe Maternal Morbidity – Moving Beyond the Delivery Hospitalization

ACOG: Pregnancy-Associated Deaths Due to Drugs, Suicide, and Homicide in the United States, 2010–2019

ABSTRACT OBJECTIVE: To estimate the prevalence of pregnancy-associated deaths due to drugs, suicide, and homicide nationwide from 2010 to 2019. METHODS: Using U.S. death certificate records from 2010 to 2019…

Read More from ACOG: Pregnancy-Associated Deaths Due to Drugs, Suicide, and Homicide in the United States, 2010–2019

ACOG: Variations in Low-Risk Cesarean Delivery Rates in the United States Using the SMFM Definition

ABSTRACT OBJECTIVE: To assess variations in low-risk cesarean delivery rates in the United States using the Society for Maternal-Fetal Medicine (SMFM) definition of low-risk for cesarean delivery and to identify…

Read More from ACOG: Variations in Low-Risk Cesarean Delivery Rates in the United States Using the SMFM Definition

ACOG: Association of Skin Incision Type With Postoperative Cesarean Delivery Complications in Morbidly Obese Patients

ABSTRACT OBJECTIVE: To assess whether Pfannenstiel skin incision compared with vertical skin incision was associated with postcesarean delivery wound complications in morbidly obese women. METHODS: We assembled a retrospective cohort…

Read More from ACOG: Association of Skin Incision Type With Postoperative Cesarean Delivery Complications in Morbidly Obese Patients

ACOG: Trends in and Factors Associated With Episiotomy in the Setting of Nonoperative Vaginal Delivery, 2000–2018

INTRODUCTION Episiotomy, an incision through the perineum to facilitate delivery, is a common obstetric procedure.1 For decades, evidence has shown that routine episiotomy has unclear benefit but substantial risk of…

Read More from ACOG: Trends in and Factors Associated With Episiotomy in the Setting of Nonoperative Vaginal Delivery, 2000–2018

ACOG: Neutralizing Antibodies and Cytokines in Breast Milk After Coronavirus Disease 2019 (COVID-19) mRNA Vaccination

ABSTRACT OBJECTIVE: To evaluate immune responses to coronavirus disease 2019 (COVID-19) mRNA-based vaccines present in breast milk and transfer of the immune responses to breastfeeding infants. METHODS: We enrolled 30…

Read More from ACOG: Neutralizing Antibodies and Cytokines in Breast Milk After Coronavirus Disease 2019 (COVID-19) mRNA Vaccination

SMFM updated, “Provider Considerations for Engaging in COVID-19 Vaccine Counseling With Pregnant and Lactating Patients,” to include the latest information on boosters.

SMFM and ACOG recommend that pregnant people receive a COVID-19 booster shot at least 6 months after their primary series for mRNA-based vaccines (ie, Pfizer or Moderna) and at least…

Read More from SMFM updated, “Provider Considerations for Engaging in COVID-19 Vaccine Counseling With Pregnant and Lactating Patients,” to include the latest information on boosters.

ACOG: Scientific Evidence Supporting Coronavirus Disease 2019 (COVID-19) Vaccine Efficacy and Safety in People Planning to Conceive or Who Are Pregnant or Lactating

ABSTRACT Three coronavirus disease 2019 (COVID-19) vaccines have been authorized for use in the United States; specifically, the Pfizer–BioNTech, Moderna, and Johnson & Johnson–Janssen COVID-19 vaccines were granted emergency use…

Read More from ACOG: Scientific Evidence Supporting Coronavirus Disease 2019 (COVID-19) Vaccine Efficacy and Safety in People Planning to Conceive or Who Are Pregnant or Lactating